[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353631-105":59,"doc-detail-353631-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","post-translational-modification-networks-in-tumor-radiosensitivity-mechanistic-insights-and-therapeutic-opportunities","Post-translational modification networks in tumor radiosensitivity: mechanistic insightsand therapeutic opportunities","","Radiotherapy is central in cancer management but intrinsic and acquired radioresistance plus dose-limiting normal-tissue toxicities reduce durable tumor control. Beyond genetic and transcriptional programs, post-translational modifications (PTMs) offer rapid, reversible regulation that rewires radiation responses across tumor and stromal compartments. This review synthesizes how PTM axes coordinate DNA damage recognition and repair choice, chromatin remodeling, checkpoint control, and cell-fate decisions, and how they shape metabolic/redox adaptation and anti-tumor immunity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/post-translational-modification-networks-in-tumor-radiosensitivity-mechanistic-insights-and-therapeutic-opportunities/353631/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/post-translational-modification-networks-in-tumor-radiosensitivity-mechanistic-insights-and-therapeutic-opportunities/353631.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does radiotherapy often fail to achieve durable tumor control?","Question",{"text":112,"@type":113},"Intrinsic and acquired radioresistance and dose-limiting toxicities in normal tissues constrain long-term tumor control. Even with improved delivery precision, these limits persist.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do post-translational modifications influence tumor radiosensitivity?",{"text":117,"@type":113},"PTMs rapidly and reversibly regulate radiation responses by coordinating DNA damage recognition and repair pathway choice, chromatin remodeling, checkpoint control, and cell-fate decisions such as apoptosis and ferroptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic opportunities are proposed from the PTM-network perspective?",{"text":121,"@type":113},"Targeting PTM writers, erasers, and readers—alone or combined with radiotherapy, DNA damage response inhibitors, epigenetic agents, and immunotherapy—may overcome resistance and improve the therapeutic window. The review emphasizes context-specific biomarkers, toxicity management, and mechanism-informed trial designs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353631,1791266558,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Lv et al. Journal of Translational Medicine (2026) 24:141  \n[https://doi.org/10.1186/s12967-025-07641-6](https://doi.org/10.1186/s12967-025-07641-6)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nPost-translational modification networks in tumor radiosensitivity: mechanistic insightsand therapeutic opportunities  \nXiaoli Lv1†, Jiao Xue1†, Jun Zhou2†, Qi Zhao1, Yandong Liu1, Lili Wang1*, Yang Jiao3* and Songbing Qin1*  \nAbstract  \nBackground Radiotherapy is a central modality in cancer management, yet intrinsic and acquired radioresistance and dose-limiting normal tissue toxicities continue to constrain durable tumor control. Beyond genetic and transcriptional programs, post-translational modifications (PTMs) provide rapid and reversible regulation that can rewire radiation responses across tumor and stromal compartments.  \nMain body This review synthesizes recent advances defining how major PTM axes, including ADP-ribosylation, ubiquitination and deubiquitination, neddylation, SUMOylation, methylation, acetylation, and lactylation, shape tumor radiosensitivity and radiation-induced injury. We highlight mechanistic links to DNA damage recognition and repair pathway choice, chromatin remodeling, checkpoint control, and cell-fate decisions encompassing apoptosis and ferroptosis. We further discuss how PTM-driven metabolic and redox adaptation influences post-irradiation signaling, and how PTMs modulate anti-tumor immunity by affecting immunogenic cell death, antigen presentation, cytokine networks, and immune checkpoint regulation within the tumor microenvironment. In addition, we summarize emerging evidence for reciprocal crosstalk between PTM enzymes and non-coding RNAs, which can act as upstream regulators, scaffolds, or effectors to reinforce context-specific modification patterns and therapeutic vulnerabilities.  \nConclusions Viewing radioresponse through a PTM-network lens reveals actionable nodes for radiosensitization and radioprotection. Targeting PTM writers, erasers, and readers, alone or in rational combinations with radiotherapy, DNA damage response inhibitors, epigenetic agents, and immunotherapy, may overcome resistance while improving the therapeutic window. Future efforts should prioritize context-specific biomarkers, on-target toxicity management, and mechanism-informed trial designs to translate PTM-guided strategies into clinically meaningful gains.  \n†Xiaoli Lv, Jiao Xue and Jun Zhou contributed equally to this work.  \n*Correspondence:  \nLili Wang [wanglili@suda.edu.cn](wanglili@suda.edu.cn)[ ](wanglili@suda.edu.cn)Yang Jiao [jiaoyang@suda.edu.cn](jiaoyang@suda.edu.cn)[ ](jiaoyang@suda.edu.cn)Songbing Qin [qin92244@163.com](qin92244@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nLv et al. Journal of Translational Medicine (2026) 24:141 Page 2 of 20  \nKeywords Post-translational modifications, Tumor radiosensitivity, DNA damage response, Radiosensitization, Therapeutic targets  \nIntroduction  \nCancer continues","cbCaisGYZ601WAPq","https://ap.wps.com/l/cbCaisGYZ601WAPq","pdf",5275905,"English","# Abstract\n# Introduction\n## Cancer burden and radiotherapy use\n## Limits of genetic/transcriptional explanations\n## PTMs as regulators of tumor radioresponse\n# Main body\n## PTM axes and radiation responses\n## Mechanistic links to DNA repair and checkpoint control\n## Cell-fate decisions and redox/metabolic adaptation\n## PTMs and anti-tumor immunity in TME\n## Crosstalk between PTM enzymes and non-coding RNAs\n# Conclusions\n## PTM-network lens for radiosensitization and radioprotection\n## Future directions for biomarkers and trial design","[{\"question\":\"Why does radiotherapy often fail to achieve durable tumor control?\",\"answer\":\"Intrinsic and acquired radioresistance and dose-limiting toxicities in normal tissues constrain long-term tumor control. Even with improved delivery precision, these limits persist.\"},{\"question\":\"How do post-translational modifications influence tumor radiosensitivity?\",\"answer\":\"PTMs rapidly and reversibly regulate radiation responses by coordinating DNA damage recognition and repair pathway choice, chromatin remodeling, checkpoint control, and cell-fate decisions such as apoptosis and ferroptosis.\"},{\"question\":\"What therapeutic opportunities are proposed from the PTM-network perspective?\",\"answer\":\"Targeting PTM writers, erasers, and readers—alone or combined with radiotherapy, DNA damage response inhibitors, epigenetic agents, and immunotherapy—may overcome resistance and improve the therapeutic window. The review emphasizes context-specific biomarkers, toxicity management, and mechanism-informed trial designs.\"}]","Post-translational modification networks in tumor radiosensitivity: mechanistic insightsand therapeutic opportunities | PDF",1790106454,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cc8f85adc27734dc2c1359c3b438f0c.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca3ffc81a831b5ace45e15d094ba10b4.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7de552499f77db81e4dbe50016cbacba.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ddbd598e07f55e4047c43d7b1cc81ba9.webp",980,1306]